1.Emergency Drug Supply Mechanism in Women and Children’s Special Hospital During Earthquake Disaster
Qunfen XU ; Yunzhu LIN ; Yantao LIU ; Lingli ZHANG
China Pharmacy 2007;0(34):-
OBJECTIVE:To explore an emergency drug supply mechanism for women and children’s special hospital during earthquake disaster. METHODS: The practice of drug supply in our hospital after "5?12" Wenchuan earthquake was analyzed. RESULTS: The daily and post-earthquake medicine supply of the hospital was guaranteed,including the drugs which supply to the medical treatment rescues team in the disaster area;and the principle and approach of emergency drug supply in women and children's special hospital during earthquake disaster has been established. CONCLUSIONS: The emer-gency drug supply in women and children’s special hospital should cover drugs used for wounded women and children in addition to those special drugs used for earthquake injuries. All the links including drug plan,drug purchase,quantity monitoring and drugs needed for rescue should be considered in detail to form a fast and smooth hospital emergency drug supply mechanism.
2.Cytological Study in vitro on Co-delivery of siRNA and Paclitaxel within Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Tumors.
Rui HUANG ; Xinyu YAO ; Yuan CHEN ; Xun SUN ; Yunzhu LIN
Journal of Biomedical Engineering 2016;33(1):108-114
Multidrug resistance (MDR) remains the major obstacle to the success of clinical cancer chemotherapy. P-glycoprotein (P-gp), encoded by the MDR1, is an important part with complex mechanisms associated with the MDR. In order to overcome the MDR of tumors, we in the present experimental design incorporated small interfering RNA (siRNA) targeting MDR1 gene and anticancer drug paclitaxel (PTX) into the solid lipid nanoparticles (SLNs) to achieve the combinational therapeutic effects of genetherapy and chemotherapy. In this study, siRNA-PTX-SLNs were successfully prepared. The cytotoxicity of blank SLNs and siRNA-PTX-SLNs in MCF-7 cells and MCF-7/ADR cells were detected by MTT; and the uptake efficiency of PTX in MCF-7/ADR cells were detected via HPLC method; quantitative real-time PCR and flow cytometry were performed to investigate the silencing effect of siRNA-PTX- SLNs on MDR1 gene in MCF-7/ADR cells. The results showed that PTX loaded SLNs could significantly inhibit the growth of tumor cells, and more importantly, the MDR tumor cells treated with siRNA-PTX-SLNs showed the lowest viability. HPLC study showed that SLNs could enhance the cellular uptake for PTX. Meanwhile, siRNA delivered by SLNs significantly decreased the P-gp expression in MDR tumor cells, thus increased the cellular accumulation of rhodamine123 as a P-gp substrate. In conclusion, the MDR1 gene could be silenced by siRNA-PTX-SLNs, which could promote the growth inhibition efficiency of PTX on tumor cells, leading to synergetic effect on MDR tumor therapy.
ATP Binding Cassette Transporter, Sub-Family B
;
genetics
;
Antineoplastic Agents
;
pharmacology
;
Breast Neoplasms
;
pathology
;
Drug Delivery Systems
;
Drug Resistance, Multiple
;
Drug Resistance, Neoplasm
;
Humans
;
Lipids
;
chemistry
;
MCF-7 Cells
;
drug effects
;
Nanoparticles
;
chemistry
;
Paclitaxel
;
pharmacology
;
RNA, Small Interfering
;
pharmacology
;
Real-Time Polymerase Chain Reaction
3.Approach to Management of Hospital Drug Storehouse Basing on Joint Commission International Accreditation
Yantao LIU ; Qunfen XU ; Yunzhu LIN ; Lingli ZHANG
China Pharmacy 1991;0(05):-
OBJECTIVE:To strengthen management of hospital drug storehouse.METHODS:According to Joint Commission International (JCI) accreditation,management of drug storehouse was guided through perfecting working system,workflow,qualification confirmation of employees,reasonable management of drug stock and information management,etc.Related investigation and discussion were carried out.RESULTS & CONCLUSIONS:Management of hospital drug storehouse combining with JCI accreditation and quality assurance system of drug storehouse management can improve workflow and management of drug storehouse,guaranteeing efficiency and quality of drug supply.
4.Practice of Zero Inventory Principle Management Mode to Achieve Optimized Workflow in Hospital Drug Supply Storeroom
Yunzhu LIN ; Qunfen XU ; Youhong CAO ; Lingli ZHANG
China Pharmacy 2007;0(25):-
OBJECTIVE: To provide references for the practice of the zero inventory management mode in hospital drug supply storeroom.METHODS: The zero inventory management mode in hospital drug supply storeroom was summarized based on experiences of hospital drug supply storeroom management in our hospital.RESULTS & CONCLUSIONS: After introduction of zero inventory management principle in hospital drug supply storeroom,the drug turnover frequency in our hospital reached 8~9 times every quarter,which has greatly lowered drug storage costs,activated the working capital,and brought down the proportion of drug fund to as low as about 15% of total hospital working capital.Therefore,establishing a reasonable managing mode suitable to hospital condition and applying zero inventory principle in the management of hospital drug supply storeroom are of importance for lowering hospital running cots and enhancing working efficiency.
5.Scientific Optimizing of Flow of Drug Purchasing in Hospital
Qunfen XU ; Youhong CAO ; Yunzhu LIN ; Yantao LIU ; Lingli ZHANG
China Pharmacy 2007;0(34):-
OBJECTIVE:To construct a high-efficiency, high-performance, low-cost flow of drug purchasing. METHODS: The defects involved in the current drug purchasing flowsheet prevalent in many hospitals were analyzed and the optimized flowsheet was put into practice by combining the actuality of our hospital. RESULTS & CONCLUSIONS: The traditional drug purchasing modality can not meet the requirement of current hospitals in that it involves large work load and high probability of error, and it is tedious and time-consuming. The establishment of drug catalog database and the online drug purchase by means of instant communication software can help simplify drug purchase flow, lessen work load, enhance work efficiency, and effectuate a high-efficiency, high-performance, low-cost flow of drug purchasing.
6.Efficacy and safety of Chushizhiyang ointment for the treatment of mild atopic dermatitis in infants: a multicenter clinical study
Chunping SHEN ; Liuhui WANG ; Hua WANG ; Jianping TANG ; Xiaoxia PENG ; Guoshuang FENG ; Yunzhu LI ; Lin MA
Chinese Journal of Dermatology 2017;50(4):279-282
Objective To evaluate the efficacy and safety of Chushizhiyang ointment for the treatment of mild atopic dermatitis in infants.Methods A multicenter,randomized,open,active-controlled clinical trial was conducted.A total of 204 infants with atopic dermatitis were enrolled and randomly divided into 2 groups to be topically treated with Chushizhiyang ointment (test group,n =103) and hydrocortisone butyrate cream (control group,n =101),respectively,for 2 weeks.The improvement of eczema area and severity index (EASI) scores and quality of life was evaluated at 7 days and 14 days after the treatment,so was the incidence of adverse events and adverse reactions.Results Ninety-eight infants in the test group and 101 in the control group were included in the full analysis set,which revealed that the disease severity significantly decreased after the treatment in both groups.The EASI scores at the baseline and on days 7 and 14 were 2.47 ± 4.04,0.92 ± 1.25 and 0.39 ± 1.04 respectively in the test group,as well as 2.13 ± 2.01,0.85 ± 1.58 and 0.45 ± 1.65 respectively in the control group.Furthermore,the test group and control group both showed that EASI scores on days 7 and 14 significantly decreased compared with those at the baseline (the test group:T =-1 666,-1 793,respectively,both P < 0.001;the control group:T =-1 951,-1 941,respectively,both P < 0.001).No significant differences in EASI scores at the baseline or on days 7 and 14 were observed between the test group and control group (all P > 0.05).The response rates in the test group and control group were 47.96% (47/98) and 55.44% (56/101) respectively on day 7,as well as 79.59% (78/98) and 84.16% (85/101) respectively on day 14,and there were also no significant differences between the two groups (both P > 0.05).The adverse reactions mainly manifested as erythema,itching and scaling in the test group,as well as hypopigmentation,telangiectasia,scaling and hyperpigmentation in the control group.No significant difference in the incidence of adverse events was found between the test group (2.9%,3/103) and control group (6.9%,7/101).Conclusion Chushizhiyang ointment shows definite efficacy for mild atopic dermatitis in infants with good safety and tolerability,and can be a teatment option for mild atopic dermatitis in infants.
7.Systematic Review on the Current Situation of Hierarchical Diagnosis and Treatment in China
Xiaomei ZHOU ; Chunsong YANG ; Yunzhu LIN
China Pharmacy 2017;28(34):4763-4766
OBJECTIVE:To systematically review the current situation and facing problems of hierarchical diagnosis and treat-ment in China,and provide basis for nation health-related decisions. METHODS:Using"hierarchical diagnosis and treatment"as keyword,relevant literatures in CNKI,VIP database,and Wanfang database from building to Jun. 2016 were retrieved. Study for current situation of hierarchical diagnosis and treatment in China was comprehensively collected,and systematical review was con-ducted from aspects of outcome evaluation indicators and facing problems. RESULTS:Totally 23 studies were included,in which, 18 were investigative studies,3 were retrospective/investigative studies,1 was retrospective study,and 1 was randomized con-trolled study. In the outcome evaluation indicators,9 took awareness of hierarchical diagnosis and treatment as review indicators, showing that the public had poor awareness;7 took the current situation as review indicator,showing that the overall current situa-tion was unsatisfactory;3 took human resources as review indicator,showing that human resources in primary medical institutions were not ideal;3 took satisfactory degree as review indicator,showing that the public were generally satisfied with hierarchical di-agnosis;2 took the implementation model as review indicator,showing that the current model had been able to promote hierarchi-cal diagnosis and treatment;2 took medical cost as review indicator,showing that individuals paid higher. In the facing problems, 19 studies suggested the imperfect systems for hierarchical diagnosis and treatment,16 suggested that primary medical treatment was limited in capability,7 suggested that patients still preferred big hospitals to primary medical institutions,and 7 suggested that it lacked publicity. CONCLUSIONS:The current situation of hierarchical diagnosis and treatment is certainly not ideal but still fac-ing many problems in China. Improving the levels in primary institutions,hierarchical diagnosis and treatment system and patients' willingness to primary medical institutions,and increasing its publicity can deeply promote the implementation of hierarchical diag-nosis and treatment and provide objective and valuable reference for health decision-making.
8.Effect of cardiac shock wave therapy on human cardiac microvascular endothelial cells and its signal con-duction pathway
Baotong HUA ; Ling ZHAO ; Hongyan CAI ; Zhiling LUO ; Yu WANG ; Lin LI ; Yunzhu PENG ; Ruijie LI ; Tao GUO
Journal of Medical Postgraduates 2016;29(7):683-687
[Abstract ] Objective Cardiac shock wave therapy (CSWT) can promote arteriogenesis in ischemic myocardia , but the mo-lecular mechanism remains unclear .The study aimed to explore the effect of CSWT on arteriogenesis in human cardiac microvascular endothelial cells ( HCMEC ) and the role of focal adhesion kinase (FAK) and Calcium-activated potassium channels (KCa) in the sig-nal conduction pathway of CSWT arteriogenesis . Methods HC-MEC cells cultured in vitro were randomly divided into control group , CSWT group , CSWT +T ( FAK inhibitor PF-573228 ) group and CSWT+F( SCa inhibitor iberiotoxin ) group.Each group received one CSWT(0.09 mJ/mm2, 200Times) 48 h after added stimulant.24 hours'conventional culture later , tests were made on the levels of endothelial nitric oxide synthase ( eNOS ) and vascular endothelial growth factor ( VEGF) mRNA as well as the changes of related protein expression . Results ①QPCR test showed that eNOS , VEGF mRNA expressions increased in CSWT group compared with control group (4.61 ±0.19 vs 3.99 ±0.17, P<0.05), while compared with CSWT group, eNOS, VEGF mRNA expressions in CSWT +T group were decreased (0.62 ±0.10 vs 0.40 ±0.02, P<0.05), eNOS, VEGF mRNA expressions in CSWT +F group were also decreased (0.53 ±0.02 vs 0.64 ±0.02, P<0.05), all the differ-ences were of statistical significance .②Western blot showed that eNOS , VEGF protein expressions increased in CSWT group compared with control group(0.63 ±0.02 vs 0.43 ±0.02, P<0.05), while compared with CSWT group , eNOS, VEGF protein expressions in CSWT+T group were decreased (0.36 ±0.01 vs 0.29 ±0.02, P<0.05), eNOS, VEGF protein expressions in CSWT +F group were also decreased (0.37 ±0.02 vs 0.30 ±0.02, P<0.05), all the differences were of statistical significance . Conclusion CSWT can improve eNOS , VEGF mRNA and protein expressions in HCMEC cells and FAK and KCa may participate in the signal conduction pathway of CSWT arteriogenesis .
9.Preparation and degradation behavior of PELGE nanoparticles.
Yourong DUAN ; Zhirong ZHANG ; Yonggang TANG ; Yunzhu LIN
Journal of Biomedical Engineering 2004;21(6):921-925
A series of poly (lacticacid-co-glycolicacid)-poly(ethylene glycol) (PLGA-PEG, PELGA) block copolymers and poly (ethylene glycol)-poly (lacticacid-co-glycolicacid)-poly (ethylene-glycol) (PELGE) was synthesized by ring-opening polymerization. PELGA nanoparticles and PELGE nanoparticles were prepared using the emulsion-solvent evaporation technique (O/W). To study the behavior and mechanism of the degradation of PELGA-NP and PELGA-NP, we determined the lactic acids by UV spectrophotometry. The method confirmed that degradation was much faster for polymers with a decrease in the LA content of the polymers or an increase in the PEG content of the polymers.
Biocompatible Materials
;
chemistry
;
Biodegradation, Environmental
;
Drug Carriers
;
Drug Delivery Systems
;
Humans
;
Lactic Acid
;
chemical synthesis
;
chemistry
;
Microspheres
;
Nanostructures
;
Nanotechnology
;
Polyesters
;
chemical synthesis
;
chemistry
;
Polyethylene Glycols
;
chemical synthesis
;
chemistry
;
Polyglactin 910
;
chemistry
;
Polyglycolic Acid
;
chemical synthesis
;
chemistry
;
Polymers
;
chemical synthesis
;
chemistry
10.Research on the Indicators of ADR Reporting by Medical Institutions in China
Rui HUANG ; Chunsong YANG ; Yu XIONG ; Yunzhu LIN
China Pharmacy 2018;29(6):721-725
OBJECTIVE:To evaluate the indicators of ADR reporting by medical institutions in China. METHODS:The indicators of ADR reporting by medical institutions in China were presented primarily by 8 pharmacy experts with focus group interview method. System assessment method was used for evidence-based analysis of primary ADR indicators. Delphi method was used to confirm the requirement,calculation formula,definition,evaluation meaning and reference value of ADR indicators. The reliability was assessed. RESULTS:Primary indicators included the rate of ADR reporting,the rate of qualified ADR,constituent ratio of severe and new ADR. A total of 30 literatures were included(15 documents of management standard,15 literature research)in system evaluation,all of which indicated the necessity and requirement of ADR reporting. But the calculation formula, definition and evaluation meaning of ADR indicators were not mentioned. By investigation with Delphi method,the range of reference value was confirmed as follows that the rate of ADR reporting was≥0.01%;the rate of qualified ADR was≥90%;the constituent ratio of severe and new ADR was≥1%. The evaluation result was reliable. CONCLUSIONS:The indicators of ADR reporting and reference lower limit value can urge medical and health institutions to report ADR actively,improve the quality of ADR reporting and strengthen the attention of medical and health institutions to severe and new ADR.